HDA
Postcard from Palm Springs 2016
Treasure your exceptions – using outliers to understand Huntington’s disease onset and progression

A new study provides the framework for finding factors that affect the onset and progression of HD By Mr. Shawn Minnig on January 12, 2017 Edited by Dr Tamara Maiuri...

A powerful message: does a toxic RNA message molecule cause harm in Huntington’s disease?

What if some problems in HD were due to something other than a harmful protein? By Dr Jeff Carroll on December 30, 2016 Edited by Dr Ed Wild Researchers have...

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington’s disease symptoms

Pfizer announces the ‘Amaryllis’ trial of a PDE-10 inhibitor drug failed to improve symptoms of HD By Dr Ed Wild on December 16, 2016 Edited by Dr Jeff Carroll Pfizer...

Important advances in next generation genome editing tools for Huntington’s Disease

Work with genome editing techniques (zinc fingers and CRISPR) brings these tools closer to use in HD clinical trials By Mr. Shawn Minnig on October 31, 2016 Edited by Dr...